Previously, we found that combination of the AXL inhibitor BMS-777607 with the S6K1 inhibitor LY-2584702 recapitulated the activity of the multikinase inhibitor AD80 to selectively induce cytotoxic responses in PTEN-deficient GBM cells in vitro (28). This evidence concerns the gene AXL and glioblastoma.